However, those patients in which the tumor had high SOX2 expression and MGMT was methylated showed a longer survival than when unmethylated with high SOX2 expression, or patients with low expression of SOX2 regardless of MGMT methylation status (Fig. 10). The gene discussed is SOX2; the disease is neoplasm.